Philosophy of Care

Cancer is not a disease that occurs in a vacuum and thus I focus not only on treating the cancer but also on assisting patients with the nutritional, social, emotional, and spiritual issues which are often ignored in modern medicine. I believe strongly in a multidisciplinary team approach to cancer including open lines of communication with both my patients and fellow physicians. Although I employ aggressive cutting edge anti-cancer treatments I am also respectful of and willing to incorporate holistic and alternative medicines into patient care. Ultimately I strive to treat each patient with the same respect and diligence I would an ailing member of my own family.

Clinical Interests

Dr. Monjazeb is a clinician scientist performing cutting edge clinical and basic science research. He is an internationally recognized expert in cancer immunotherapy. His research is focused on understanding how the immune system can be harnessed to fight cancer and how radiotherapy can be used to promote anti-tumor immune responses. Through his own personal research and national leadership roles in cancer immunotherapy he is able to translate his research into the clinic offering patients novel treatment strategies for cancer.

Dr. Monjazeb has a clinical focus on the treatment of gastrointestinal malignancies (including esophageal cancer), sarcoma, melanoma and breast cancers. He specializes in various radiotherapy techniques including intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT), stereotactic body radiotherapy (SAR / SBRT) and high dose rate brachytherapy. Dr. Monjazeb is a principal investigator on a number of clinical trials testing novel cancer immunotherapy approaches and sees patients with various types of cancers for consideration of these trials.

Research/Academic Interests

Dr. Monjazeb's research is focused on understanding how the immune system can be harnessed to fight cancer, how radiotherapy can be used to promote anti-tumor immune responses, and translating novel cancer immunotherapy strategies from the laboratory into the clinic.

Division

Radiation Oncology

Center/Program Affiliation

UC Davis Comprehensive Cancer Center